Tvardi Therapeutics (TVRD) Other Non-Current Assets (2013 - 2026)
Tvardi Therapeutics (TVRD) recorded Other Non-Current Assets of $17,000 in Q2 2026, unchanged from $17,000 a year earlier and unchanged from the prior quarter.
Tvardi Therapeutics (TVRD) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Starting with Q4 2013, Tvardi Therapeutics' Other Non-Current Assets history includes 47 quarters.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of -47.0% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $2.81 million in FY2024 (+87.4%), $1.5 million in FY2023 and $408,000 in FY2021 (unchanged).
- Quarterly Other Non-Current Assets has ranged from $17,000 in Q2 2025 to $2.81 million in Q4 2024 over the past five years.
- On a year-over-year basis, Other Non-Current Assets rose in 1 of the last four quarters, with an average decline of 27.7%.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 267.6% in Q3 2023, against a decline of 99.4% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $17,000 (Q1 2026), $17,000 (Q4 2025) and $17,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Tvardi Therapeutics | 12.48 Mn | -95.62 Mn | - | 17,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 2.83 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Sep 30, 2022 | 408,000.00 |
| Jun 30, 2022 | 408,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 408,000.00 |
| Sep 30, 2021 | 408,000.00 |
| Jun 30, 2021 | 408,000.00 |
| Mar 31, 2021 | 408,000.00 |
| Dec 31, 2020 | 408,000.00 |
| Sep 30, 2020 | 408,000.00 |
Tvardi Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TVRD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();